Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor

Guo, LT; Zhang, HJ; Chen, BA

Chen, BA (reprint author), Southeast Univ, Sch Med, Affiliated Zhongda Hosp, Dept Hematol & Oncol,Key Dept Jiangsu Med, Dingjiaqiao 87, Nanjing 210009, Jiangsu, Peoples R China.

JOURNAL OF CANCER, 2017; 8 (3): 410

Abstract

Targeted immunotherapy has become the most promising approach for tumor patients. Programmed death-1 (PD-1), an inhibitory receptor expressed on activ......

Full Text Link